% | $
Quotes you view appear here for quick access.

Celsion Corp. Message Board

  • upsterjack upsterjack Jan 20, 2013 3:37 PM Flag

    CLSN The Misguidence of Feurstein-Ratain Rule

    Anyone can selectively pick a universe of Biotech corporations and show 100 percent failure of phase 3 trials.

    To be true to the reader is another thing. There are three Biotech companies that come to mind in 2012 that had market caps smaller than 300 million several months before positive phase 3 result. Their positive results brought their market caps well over 500 million. Their ticker symbols are ACAD, SRPT, ARNA. Go back and check their shares outstanding, stock price and calculate their market caps four months prior to anoucements.

    The article posted by the Motley Fools is Foolish, distorted and not truthful. Why anybody would follow a company with Fool in it is beyond me.

    Don't let misguided information scare you from a position. Stay long and strong!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.41-0.09(-6.00%)May 27 4:00 PMEDT